ASKA Pharmaceutical Holdings Co (TSE:4886) Moat Score: 0/10 (As of Jul. 10, 2026)


TSE:4886 ASKA Pharmaceutical Holdings Co Ltd TSE:4886
62 GF Score
Price 円2,259.00
GF Value 円2,400.69
Valuation Fairly Valued
View Full Analysis

What is ASKA Pharmaceutical Holdings Co Moat Score?

ASKA Pharmaceutical Holdings Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

ASKA Pharmaceutical Holdings Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes ASKA Pharmaceutical Holdings Co might have No Moat - No discernible moat.

ASKA Pharmaceutical Holdings Co  (TSE:4886) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

ASKA Pharmaceutical Holdings Co Moat Score Related Terms

TSE:4886
62GF Score
ASKA Pharmaceutical Holdings Co Ltd TSE:4886
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?

Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of 円2,259.00 is trading 5.9% below its estimated GF Value™ of 円2,400.69. GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4886:

  • Moat Score: 0
  • GF Value™: 円2,400.69 vs. price of 円2,259.00 (5.9% below fair value)
  • GF Score™: 62/100

No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ASKA Pharmaceutical Holdings Co Business Description

Address 2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
62GF Score

Get the complete analysis for TSE:4886

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,259.00
Price
円2,400.69
GF Value